Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGM | P11217 | 19/20 | 0.62 |
| ▸ | PYGL | P06737 | 18/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4072118 | 1.00 | PYGM (0.62) | PYGMPYGLALOX15 | |
| SCHEMBL9865950 | 0.91 | PYGM (0.52) | PYGMPYGL | |
| SCHEMBL9864934 | 0.90 | PYGM (0.49) | PYGMPYGL | |
| SCHEMBL9865516 | 0.89 | PYGL (0.48) | PYGMPYGL | |
| SCHEMBL9867642 | 0.87 | PYGL (0.46) | PYGMPYGL | |
| SCHEMBL9865794 | 0.86 | PYGM (0.46) | PYGMPYGL | |
| SCHEMBL10425160 | 0.86 | PYGM (0.46) | PYGMPYGLALOX15 | |
| SCHEMBL9829022 | 0.86 | PYGL (0.48) | PYGMPYGLALOX15 | |
| SCHEMBL10659301 | 0.86 | PYGL (0.52) | PYGMPYGL | |
| SCHEMBL9865957 | 0.84 | PYGL (0.44) | PYGMPYGL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4561704-A2 | USE OF GLYCOGEN METABOLISM INHIBITORS FOR THE TREATMENT OF CANCER | The University Of Vermont (US) | 2025-06-04 | — | — | EP | claimed |
| WO-2024026458-A2 | USE OF GLYCOGEN METABOLISM INHIBITORS FOR THE TREATMENT OF CANCER | THE UNIVERSITY OF VERMONT (US) | 2024-02-01 | — | — | WO | claimed |
| EP-4110344-A2 | USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER | The University Of Vermont (US) | 2023-01-04 | — | — | EP | claimed |
| EP-4561704-A2 | USE OF GLYCOGEN METABOLISM INHIBITORS FOR THE TREATMENT OF CANCER | The University Of Vermont (US) | 2025-06-04 | — | — | EP | disclosed |
| WO-2024026458-A2 | USE OF GLYCOGEN METABOLISM INHIBITORS FOR THE TREATMENT OF CANCER | THE UNIVERSITY OF VERMONT (US) | 2024-02-01 | — | — | WO | disclosed |
| EP-4110344-A2 | USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER | The University Of Vermont (US) | 2023-01-04 | — | — | EP | disclosed |